Oncology & Cancer

Review dives deep into probiotics for colorectal cancer

Colorectal cancer (CRC) is expected to contribute to a burden of 3.2 million new cases and 1.6 million deaths by 2040. CRC prevention strategies target lifestyle changes, screening high-risk individuals, and polyp removal, ...

Oncology & Cancer

Promising results for a new bowel cancer treatment

A new tablet treatment called divarasib has shown it is very effective in treating a challenging type of bowel (colorectal) cancer associated with the KRAS G12C mutation.

page 8 from 40